JP2009533451A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533451A5 JP2009533451A5 JP2009505469A JP2009505469A JP2009533451A5 JP 2009533451 A5 JP2009533451 A5 JP 2009533451A5 JP 2009505469 A JP2009505469 A JP 2009505469A JP 2009505469 A JP2009505469 A JP 2009505469A JP 2009533451 A5 JP2009533451 A5 JP 2009533451A5
- Authority
- JP
- Japan
- Prior art keywords
- patch
- subject
- triptan compound
- delivery
- stage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZISSAWUMDACLOM-UHFFFAOYSA-N methyl-t-butylethan Natural products CC(C)C(C)(C)C ZISSAWUMDACLOM-UHFFFAOYSA-N 0.000 claims description 82
- -1 triptan compound Chemical class 0.000 claims description 73
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical group CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 claims description 50
- 238000012384 transportation and delivery Methods 0.000 claims description 47
- 229960003708 sumatriptan Drugs 0.000 claims description 43
- 150000003839 salts Chemical class 0.000 claims description 30
- 206010015150 Erythema Diseases 0.000 claims description 15
- 239000008280 blood Substances 0.000 claims description 15
- 210000004369 blood Anatomy 0.000 claims description 15
- 230000002460 anti-migrenic effect Effects 0.000 claims description 10
- 230000009969 flowable effect Effects 0.000 claims description 10
- 239000000017 hydrogel Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 229960005254 naratriptan Drugs 0.000 claims description 8
- UNHGSHHVDNGCFN-UHFFFAOYSA-N naratriptan Chemical compound C=12[CH]C(CCS(=O)(=O)NC)=CC=C2N=CC=1C1CCN(C)CC1 UNHGSHHVDNGCFN-UHFFFAOYSA-N 0.000 claims description 8
- 208000019695 Migraine disease Diseases 0.000 claims description 7
- 206010027599 migraine Diseases 0.000 claims description 7
- 229960000658 sumatriptan succinate Drugs 0.000 claims description 7
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical group [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 230000001225 therapeutic effect Effects 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- 229940125684 antimigraine agent Drugs 0.000 claims description 3
- 239000002282 antimigraine agent Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000007933 dermal patch Substances 0.000 claims description 2
- 230000007794 irritation Effects 0.000 claims description 2
- 238000012423 maintenance Methods 0.000 claims description 2
- 238000012385 systemic delivery Methods 0.000 claims description 2
- 206010019233 Headaches Diseases 0.000 claims 2
- 208000000060 Migraine with aura Diseases 0.000 claims 2
- 231100000869 headache Toxicity 0.000 claims 2
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 claims 1
- 206010050258 Basilar migraine Diseases 0.000 claims 1
- 208000006561 Cluster Headache Diseases 0.000 claims 1
- 230000002567 autonomic effect Effects 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000018912 cluster headache syndrome Diseases 0.000 claims 1
- 206010067039 familial hemiplegic migraine Diseases 0.000 claims 1
- 208000017420 migraine with brainstem aura Diseases 0.000 claims 1
- 230000001314 paroxysmal effect Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 238000000034 method Methods 0.000 description 77
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 150000003890 succinate salts Chemical group 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79181906P | 2006-04-13 | 2006-04-13 | |
| US60/791,819 | 2006-04-13 | ||
| US81413106P | 2006-06-16 | 2006-06-16 | |
| US60/814,131 | 2006-06-16 | ||
| PCT/US2007/009000 WO2007120747A2 (en) | 2006-04-13 | 2007-04-12 | Transdermal methods and systems for the delivery of anti-migraine compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014141927A Division JP5925844B2 (ja) | 2006-04-13 | 2014-07-10 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009533451A JP2009533451A (ja) | 2009-09-17 |
| JP2009533451A5 true JP2009533451A5 (enExample) | 2010-05-27 |
| JP5580042B2 JP5580042B2 (ja) | 2014-08-27 |
Family
ID=38610170
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009505469A Expired - Fee Related JP5580042B2 (ja) | 2006-04-13 | 2007-04-12 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
| JP2014141927A Expired - Fee Related JP5925844B2 (ja) | 2006-04-13 | 2014-07-10 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
| JP2016084282A Ceased JP2016163723A (ja) | 2006-04-13 | 2016-04-20 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014141927A Expired - Fee Related JP5925844B2 (ja) | 2006-04-13 | 2014-07-10 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
| JP2016084282A Ceased JP2016163723A (ja) | 2006-04-13 | 2016-04-20 | 抗片頭痛化合物の送達のための経皮的方法およびシステム |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US7973058B2 (enExample) |
| EP (1) | EP2012871A4 (enExample) |
| JP (3) | JP5580042B2 (enExample) |
| CN (2) | CN104138634B (enExample) |
| AU (1) | AU2007238685B2 (enExample) |
| BR (1) | BRPI0709965C2 (enExample) |
| CA (2) | CA2935569A1 (enExample) |
| EA (1) | EA023147B1 (enExample) |
| HK (1) | HK1203867A1 (enExample) |
| IL (1) | IL194553A (enExample) |
| MX (1) | MX2008012922A (enExample) |
| NZ (2) | NZ610790A (enExample) |
| WO (1) | WO2007120747A2 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA023147B1 (ru) * | 2006-04-13 | 2016-04-29 | Тева Фармасьютикалс Интернешнл Гмбх | Трансдермальный пластырь для лечения мигрени |
| ES2563061T3 (es) * | 2008-04-28 | 2016-03-10 | Zogenix, Inc. | Nuevas formulaciones para el tratamiento de la migraña |
| US8155737B2 (en) | 2008-06-19 | 2012-04-10 | Nupathe, Inc. | Pharmacokinetics of iontophoretic sumatriptan administration |
| AU2009259601B2 (en) * | 2008-06-19 | 2014-09-18 | Lts Lohmann Therapie-Systeme Ag | Composition for transdermal delivery of cationic active agents |
| US8366600B2 (en) | 2008-06-19 | 2013-02-05 | Nupathe Inc. | Polyamine enhanced formulations for triptan compound iontophoresis |
| AU2009262967C1 (en) | 2008-06-25 | 2015-12-24 | Fe3 Medical, Inc | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
| AU2009335085B2 (en) * | 2008-12-30 | 2015-11-05 | Teva Pharmaceuticals International Gmbh | Electronic control of drug delivery system |
| US8190252B2 (en) * | 2009-02-12 | 2012-05-29 | Incube Labs, Llc | Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes |
| US9008765B2 (en) | 2009-02-12 | 2015-04-14 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings |
| US8348922B2 (en) * | 2009-02-12 | 2013-01-08 | Incube Labs, Llc | Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent |
| US8961492B2 (en) | 2009-02-12 | 2015-02-24 | Incube Labs, Llc | System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
| US8821945B2 (en) | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
| WO2010151845A2 (en) * | 2009-06-26 | 2010-12-29 | Incube Labs, Llc | Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use |
| EA201270227A1 (ru) * | 2009-08-10 | 2012-10-30 | Нюпэф Инк. | Способы ионофоретического лечения тошноты и мигрени |
| WO2011044175A2 (en) | 2009-10-06 | 2011-04-14 | Incube Labs, Llc | Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes |
| WO2011046927A1 (en) * | 2009-10-13 | 2011-04-21 | Nupathe,Inc. | Transdermal methods and systems for the delivery of rizatriptan |
| US8685038B2 (en) | 2009-12-07 | 2014-04-01 | Incube Labs, Llc | Iontophoretic apparatus and method for marking of the skin |
| WO2011100376A2 (en) * | 2010-02-10 | 2011-08-18 | Incube Labs, Llc | Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
| WO2012025239A1 (en) | 2010-08-27 | 2012-03-01 | Grünenthal GmbH | Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators |
| AR082732A1 (es) | 2010-08-27 | 2012-12-26 | Gruenenthal Gmbh | 2-oxiquinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3 |
| AU2012230701B2 (en) | 2011-03-24 | 2016-09-29 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents |
| US9744353B2 (en) | 2012-11-14 | 2017-08-29 | Teva Pharmaceuticals International Gmbh | Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device |
| US9918932B2 (en) | 2016-02-19 | 2018-03-20 | Zosano Pharma Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines |
| GB2554455A (en) | 2016-09-29 | 2018-04-04 | Feeligreen Sa | Skin treatment device and method for delivery of an active ingredient into the human skin by means of iontophoresis, using an array of electrodes |
| US11660264B2 (en) | 2017-08-23 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
| JP7285259B2 (ja) * | 2017-09-12 | 2023-06-01 | エルテーエス ローマン テラピー－ジステーメ アーゲー | イオントフォレーシス用マイクロニードルデバイス |
| US11318292B2 (en) * | 2018-05-28 | 2022-05-03 | Microneedles Inc. | Microneedle patch for transdermal injections |
| US11660265B2 (en) | 2018-06-28 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
| KR20220053554A (ko) | 2019-06-28 | 2022-04-29 | 패스포트 테크놀로지스, 인크. | 트립탄 미세천공 전달 시스템 |
| EP3990063A4 (en) * | 2019-06-28 | 2023-07-05 | PassPort Technologies, Inc. | METHODS AND SYSTEMS FOR CONTROLLING ENERGY DELIVERY TO FILAMENT DEVICES |
| US11364225B2 (en) | 2019-08-21 | 2022-06-21 | Bn Intellectual Properties, Inc. | Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same |
Family Cites Families (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4856188A (en) * | 1984-10-12 | 1989-08-15 | Drug Delivery Systems Inc. | Method for making disposable and/or replenishable transdermal drug applicators |
| US4557723A (en) * | 1983-08-18 | 1985-12-10 | Drug Delivery Systems Inc. | Applicator for the non-invasive transcutaneous delivery of medicament |
| US5651768A (en) * | 1983-08-18 | 1997-07-29 | Drug Delivery Systems, Inc. | Transdermal drug applicator and electrodes therefor |
| US5605536A (en) | 1983-08-18 | 1997-02-25 | Drug Delivery Systems Inc. | Transdermal drug applicator and electrodes therefor |
| US4883457A (en) * | 1983-08-18 | 1989-11-28 | Drug Delivery Systems Inc. | Disposable and/or replenishable transdermal drug applicators and methods of manufacturing same |
| US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
| US4822802A (en) * | 1987-02-24 | 1989-04-18 | Alza Corporation | Method of fentanly administration for postoperative pain relief |
| US4865582A (en) * | 1987-06-05 | 1989-09-12 | Drug Delivery Systems Inc. | Disposable transdermal drug applicators |
| US5162042A (en) * | 1988-07-05 | 1992-11-10 | Alza Corporation | Electrotransport transdermal system |
| US4927408A (en) * | 1988-10-03 | 1990-05-22 | Alza Corporation | Electrotransport transdermal system |
| US5207752A (en) | 1990-03-30 | 1993-05-04 | Alza Corporation | Iontophoretic drug delivery system with two-stage delivery profile |
| DE4014913C2 (de) * | 1990-05-10 | 1996-05-15 | Lohmann Therapie Syst Lts | Miniaturisiertes transdermales therapeutisches System für die Iontophorese |
| WO1995025562A1 (en) | 1992-06-02 | 1995-09-28 | Alza Corporation | Electrotransport drug delivery device |
| DE4314976C1 (de) * | 1993-05-06 | 1994-10-06 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung |
| US5807571A (en) * | 1993-05-06 | 1998-09-15 | Lts Lohmann Therapie-Systeme Gmbh | Transdermal therapeutic systems for administering indole serotonin agonists |
| US5458569A (en) * | 1993-06-08 | 1995-10-17 | Becton Dickinson And Company | Wearable iontophoresis system |
| PH31437A (en) * | 1993-08-27 | 1998-11-03 | Janssen Pharmaceutica Nv | Tontophoretic delivery of an antimigrane drug. |
| US5533971A (en) * | 1993-09-03 | 1996-07-09 | Alza Corporation | Reduction of skin irritation during electrotransport |
| US5697896A (en) * | 1994-12-08 | 1997-12-16 | Alza Corporation | Electrotransport delivery device |
| JPH08317997A (ja) * | 1995-03-17 | 1996-12-03 | Takeda Chem Ind Ltd | 経皮透過方法 |
| US5700481A (en) * | 1995-03-17 | 1997-12-23 | Takeda Chemical Industries, Ltd. | Transdermal drug delivery process |
| IE960312A1 (en) * | 1995-06-02 | 1996-12-11 | Alza Corp | An electrotransport delivery device with voltage boosting¹circuit |
| CN1147329C (zh) * | 1995-06-05 | 2004-04-28 | 阿尔萨公司 | 用于经皮肤电输送芬太尼和苏芬太尼的装置 |
| US6425892B2 (en) * | 1995-06-05 | 2002-07-30 | Alza Corporation | Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| US6216033B1 (en) * | 1996-05-22 | 2001-04-10 | Alza Corporation | Device for transdermal electrotransport delivery of fentanyl and sufentanil |
| US5983130A (en) * | 1995-06-07 | 1999-11-09 | Alza Corporation | Electrotransport agent delivery method and apparatus |
| US6245347B1 (en) * | 1995-07-28 | 2001-06-12 | Zars, Inc. | Methods and apparatus for improved administration of pharmaceutically active compounds |
| US5688232A (en) | 1995-09-28 | 1997-11-18 | Becton Dickinson And Company | Iontophoretic drug delivery device having an improved controller |
| US5941843A (en) * | 1996-07-12 | 1999-08-24 | Empi, Inc. | Iontophoresis electrode |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5882677A (en) * | 1997-09-30 | 1999-03-16 | Becton Dickinson And Company | Iontophoretic patch with hydrogel reservoir |
| JP4290271B2 (ja) | 1998-04-14 | 2009-07-01 | 久光製薬株式会社 | 経皮透過方法 |
| SE9802864D0 (sv) * | 1998-08-27 | 1998-08-27 | Pharmacia & Upjohn Ab | Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder |
| EP1170029B1 (en) | 1999-04-12 | 2009-03-11 | Hisamitsu Pharmaceutical Co., Inc. | Device for iontophoresis |
| US6312716B1 (en) * | 1999-05-10 | 2001-11-06 | Peierce Management Llc | Patch and method for transdermal delivery of bupropion base |
| US6385488B1 (en) | 1999-05-20 | 2002-05-07 | Vyteris, Inc. | Circuits for increasing the reliability of an iontophoretic system |
| US6421561B1 (en) * | 1999-12-30 | 2002-07-16 | Birch Point Medical, Inc. | Rate adjustable drug delivery system |
| SI1307194T2 (sl) * | 2000-07-31 | 2011-07-29 | Nycomed Danmark Aps | Sestavek fentanila za nazalno dejanje |
| US6653014B2 (en) * | 2001-05-30 | 2003-11-25 | Birch Point Medical, Inc. | Power sources for iontophoretic drug delivery systems |
| WO2003032983A1 (en) * | 2001-06-05 | 2003-04-24 | Ronald Aung-Din | Transdermal migraine therapy |
| JP4394444B2 (ja) * | 2001-10-24 | 2010-01-06 | パワー ペーパー リミティド | 活性物質の制御された皮膚内デリバリーのためのデバイス及び方法 |
| EP1478400A1 (en) * | 2002-02-26 | 2004-11-24 | Ortho-McNeil Pharmaceutical, Inc. | Therapy for the treatment of migraine comprising anticonvulsant derivatives and antimigraine agents |
| JP4191951B2 (ja) | 2002-04-25 | 2008-12-03 | ソントル ファルマペプティド | 抗微生物剤投与装置および組立品 |
| CA2512854C (en) * | 2002-06-28 | 2010-02-09 | Alza Corporation | A reservoir for use in electrotransport drug delivery |
| US6745071B1 (en) * | 2003-02-21 | 2004-06-01 | Birch Point Medical, Inc. | Iontophoretic drug delivery system |
| US20040242770A1 (en) * | 2003-04-16 | 2004-12-02 | Feldstein Mikhail M. | Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith |
| US8734421B2 (en) * | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
| US20050228336A1 (en) * | 2004-04-07 | 2005-10-13 | Preston Keusch | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability |
| UY28935A1 (es) | 2004-06-03 | 2005-07-29 | Alza Corp | Sistema y metodo para la administracion transdermica de un anticoagulante |
| US7537590B2 (en) * | 2004-07-30 | 2009-05-26 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
| US7856263B2 (en) * | 2005-04-22 | 2010-12-21 | Travanti Pharma Inc. | Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis |
| JP2009509674A (ja) * | 2005-09-30 | 2009-03-12 | Ｔｔｉ・エルビュー株式会社 | 活性物質の全身送達のためのイオントフォレーシス方法及び装置 |
| EA023147B1 (ru) | 2006-04-13 | 2016-04-29 | Тева Фармасьютикалс Интернешнл Гмбх | Трансдермальный пластырь для лечения мигрени |
-
2007
- 2007-04-12 EA EA200802146A patent/EA023147B1/ru not_active IP Right Cessation
- 2007-04-12 MX MX2008012922A patent/MX2008012922A/es active IP Right Grant
- 2007-04-12 AU AU2007238685A patent/AU2007238685B2/en not_active Ceased
- 2007-04-12 NZ NZ610790A patent/NZ610790A/en not_active IP Right Cessation
- 2007-04-12 EP EP07755312.1A patent/EP2012871A4/en not_active Withdrawn
- 2007-04-12 CA CA2935569A patent/CA2935569A1/en not_active Abandoned
- 2007-04-12 NZ NZ596498A patent/NZ596498A/xx unknown
- 2007-04-12 WO PCT/US2007/009000 patent/WO2007120747A2/en not_active Ceased
- 2007-04-12 BR BRC20709965-7A patent/BRPI0709965C2/pt not_active IP Right Cessation
- 2007-04-12 JP JP2009505469A patent/JP5580042B2/ja not_active Expired - Fee Related
- 2007-04-12 CN CN201410110715.2A patent/CN104138634B/zh not_active Expired - Fee Related
- 2007-04-12 CN CN200780022405.3A patent/CN101472644B/zh not_active Expired - Fee Related
- 2007-04-12 CA CA2650412A patent/CA2650412C/en not_active Expired - Fee Related
-
2008
- 2008-07-28 US US12/181,142 patent/US7973058B2/en not_active Expired - Fee Related
- 2008-10-06 IL IL194553A patent/IL194553A/en active IP Right Grant
-
2011
- 2011-05-11 US US13/105,562 patent/US9272137B2/en not_active Expired - Fee Related
- 2011-05-11 US US13/105,585 patent/US8470853B2/en not_active Expired - Fee Related
-
2014
- 2014-07-10 JP JP2014141927A patent/JP5925844B2/ja not_active Expired - Fee Related
-
2015
- 2015-05-06 HK HK15104294.8A patent/HK1203867A1/xx unknown
-
2016
- 2016-02-26 US US15/055,312 patent/US20160317464A1/en not_active Abandoned
- 2016-04-20 JP JP2016084282A patent/JP2016163723A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009533451A5 (enExample) | ||
| JP5580042B2 (ja) | 抗片頭痛化合物の送達のための経皮的方法およびシステム | |
| CN100333723C (zh) | 用于治疗帕金森病的罗替伐汀离子电渗给药 | |
| US20030093057A1 (en) | Methods and formulations for photodynamic therapy | |
| JP6002179B2 (ja) | トリプタン化合物イオントフォレシス用のポリアミン強化製剤 | |
| US20110087153A1 (en) | Transdermal Methods And Systems For The Delivery Of Rizatriptan | |
| US9427578B2 (en) | Pharmacokinetics of iontophoretic sumatriptan administration | |
| AU2015203213B2 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds | |
| AU2012261753B2 (en) | Transdermal methods and systems for the delivery of anti-migraine compounds |